# Hyperintense: Midlife Hypertension and the Brain

> **NCT06175663** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 130 (estimated)

## Conditions studied

- Hypertension
- Small Vessel Cerebrovascular Disease

## Interventions

- **DRUG:** Antihypertensive medication withdrawal

## Key facts

- **NCT ID:** NCT06175663
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-06
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06175663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06175663, "Hyperintense: Midlife Hypertension and the Brain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06175663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*